 | • レポートコード：QYR9ST00380 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のバイオシミラー市場について調査・分析し、以下の構成でお届け致します。バイオシミラーの種類別には、人間用成長ホルモン、モノクローナル抗体、インスリン、ペプチド、エリスロポエチン、その他に、用途別には、腫瘍学、慢性および自己免疫疾患、成長ホルモン欠乏症、感染症、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別バイオシミラー売上データ ・地域別バイオシミラー市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別バイオシミラー市場規模：人間用成長ホルモン、モノクローナル抗体、インスリン、ペプチド、エリスロポエチン、その他 ・用途別バイオシミラー市場規模：腫瘍学、慢性および自己免疫疾患、成長ホルモン欠乏症、感染症、その他 ・主要メーカーの企業情報：Allergan plc、BIOCAD、Biocon、BioXpress Therapeutics、Boehringer Ingelheim、Celltrion、Coherus BioSciences、Dr. Reddy’s Laboratories、Genor BioPharma、Intas Pharmaceuticals Limited、Novartis、Pfizer、Reliance Life Sciences ・バイオシミラーの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.The global Biosimilar market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 25.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biosimilar market based on company, product type, end user and key regions.
This report studies the global market size of Biosimilar in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosimilar in these regions.
This research report categorizes the global Biosimilar market by top players/brands, region, type and end user. This report also studies the global Biosimilar market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics
Boehringer Ingelheim
Celltrion
Coherus BioSciences
Dr. Reddy’s Laboratories
Genor BioPharma
Intas Pharmaceuticals Limited
Novartis
Pfizer
Reliance Life Sciences
Market size by Product
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
Market size by End User
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Biosimilar market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Biosimilar market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biosimilar companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Biosimilar submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Biosimilar are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biosimilar market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Biosimilar Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biosimilar Market Size Growth Rate by Product
1.4.2 Human Growth Hormones
1.4.3 Monoclonal Antibodies
1.4.4 Insulin
1.4.5 Peptides
1.4.6 Erythropoietin
1.4.7 Others
1.5 Market by End User
1.5.1 Global Biosimilar Market Size Growth Rate by End User
1.5.2 Oncology
1.5.3 Chronic and Autoimmune Diseases
1.5.4 Growth Hormone Deficiency
1.5.5 Infectious Diseases
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biosimilar Market Size
2.1.1 Global Biosimilar Revenue 2014-2025
2.1.2 Global Biosimilar Sales 2014-2025
2.2 Biosimilar Growth Rate by Regions
2.2.1 Global Biosimilar Sales by Regions
2.2.2 Global Biosimilar Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Biosimilar Sales by Manufacturers
3.1.1 Biosimilar Sales by Manufacturers
3.1.2 Biosimilar Sales Market Share by Manufacturers
3.1.3 Global Biosimilar Market Concentration Ratio (CR5 and HHI)
3.2 Biosimilar Revenue by Manufacturers
3.2.1 Biosimilar Revenue by Manufacturers (2014-2019)
3.2.2 Biosimilar Revenue Share by Manufacturers (2014-2019)
3.3 Biosimilar Price by Manufacturers
3.4 Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilar Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Biosimilar Sales by Product
4.2 Global Biosimilar Revenue by Product
4.3 Biosimilar Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Biosimilar Breakdown Data by End User
6 North America
6.1 North America Biosimilar by Countries
6.1.1 North America Biosimilar Sales by Countries
6.1.2 North America Biosimilar Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Biosimilar by Product
6.3 North America Biosimilar by End User
7 Europe
7.1 Europe Biosimilar by Countries
7.1.1 Europe Biosimilar Sales by Countries
7.1.2 Europe Biosimilar Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biosimilar by Product
7.3 Europe Biosimilar by End User
8 Asia Pacific
8.1 Asia Pacific Biosimilar by Countries
8.1.1 Asia Pacific Biosimilar Sales by Countries
8.1.2 Asia Pacific Biosimilar Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Biosimilar by Product
8.3 Asia Pacific Biosimilar by End User
9 Central & South America
9.1 Central & South America Biosimilar by Countries
9.1.1 Central & South America Biosimilar Sales by Countries
9.1.2 Central & South America Biosimilar Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Biosimilar by Product
9.3 Central & South America Biosimilar by End User
10 Middle East and Africa
10.1 Middle East and Africa Biosimilar by Countries
10.1.1 Middle East and Africa Biosimilar Sales by Countries
10.1.2 Middle East and Africa Biosimilar Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Biosimilar by Product
10.3 Middle East and Africa Biosimilar by End User
11 Company Profiles
11.1 Allergan plc
11.1.1 Allergan plc Company Details
11.1.2 Company Business Overview
11.1.3 Allergan plc Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Allergan plc Biosimilar Products Offered
11.1.5 Allergan plc Recent Development
11.2 BIOCAD
11.2.1 BIOCAD Company Details
11.2.2 Company Business Overview
11.2.3 BIOCAD Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.2.4 BIOCAD Biosimilar Products Offered
11.2.5 BIOCAD Recent Development
11.3 Biocon
11.3.1 Biocon Company Details
11.3.2 Company Business Overview
11.3.3 Biocon Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Biocon Biosimilar Products Offered
11.3.5 Biocon Recent Development
11.4 BioXpress Therapeutics
11.4.1 BioXpress Therapeutics Company Details
11.4.2 Company Business Overview
11.4.3 BioXpress Therapeutics Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BioXpress Therapeutics Biosimilar Products Offered
11.4.5 BioXpress Therapeutics Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Company Business Overview
11.5.3 Boehringer Ingelheim Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Boehringer Ingelheim Biosimilar Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 Celltrion
11.6.1 Celltrion Company Details
11.6.2 Company Business Overview
11.6.3 Celltrion Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Celltrion Biosimilar Products Offered
11.6.5 Celltrion Recent Development
11.7 Coherus BioSciences
11.7.1 Coherus BioSciences Company Details
11.7.2 Company Business Overview
11.7.3 Coherus BioSciences Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Coherus BioSciences Biosimilar Products Offered
11.7.5 Coherus BioSciences Recent Development
11.8 Dr. Reddy’s Laboratories
11.8.1 Dr. Reddy’s Laboratories Company Details
11.8.2 Company Business Overview
11.8.3 Dr. Reddy’s Laboratories Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Dr. Reddy’s Laboratories Biosimilar Products Offered
11.8.5 Dr. Reddy’s Laboratories Recent Development
11.9 Genor BioPharma
11.9.1 Genor BioPharma Company Details
11.9.2 Company Business Overview
11.9.3 Genor BioPharma Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Genor BioPharma Biosimilar Products Offered
11.9.5 Genor BioPharma Recent Development
11.10 Intas Pharmaceuticals Limited
11.10.1 Intas Pharmaceuticals Limited Company Details
11.10.2 Company Business Overview
11.10.3 Intas Pharmaceuticals Limited Biosimilar Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Intas Pharmaceuticals Limited Biosimilar Products Offered
11.10.5 Intas Pharmaceuticals Limited Recent Development
11.11 Novartis
11.12 Pfizer
11.13 Reliance Life Sciences
12 Future Forecast
12.1 Biosimilar Market Forecast by Regions
12.1.1 Global Biosimilar Sales Forecast by Regions 2019-2025
12.1.2 Global Biosimilar Revenue Forecast by Regions 2019-2025
12.2 Biosimilar Market Forecast by Product
12.2.1 Global Biosimilar Sales Forecast by Product 2019-2025
12.2.2 Global Biosimilar Revenue Forecast by Product 2019-2025
12.3 Biosimilar Market Forecast by End User
12.4 North America Biosimilar Forecast
12.5 Europe Biosimilar Forecast
12.6 Asia Pacific Biosimilar Forecast
12.7 Central & South America Biosimilar Forecast
12.8 Middle East and Africa Biosimilar Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biosimilar Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Biosimilar Product Picture
Table Biosimilar Market Segments
Table Key Manufacturers Biosimilar Covered
Table Global Biosimilar Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Biosimilar Sales Market Share by Product 2014-2025
Figure Human Growth Hormones Product Picture
Table Major Manufacturers of Human Growth Hormones
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Insulin Product Picture
Table Major Manufacturers of Insulin
Figure Peptides Product Picture
Table Major Manufacturers of Peptides
Figure Erythropoietin Product Picture
Table Major Manufacturers of Erythropoietin
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Biosimilar Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Oncology
Figure Chronic and Autoimmune Diseases
Figure Growth Hormone Deficiency
Figure Infectious Diseases
Figure Others
Figure Biosimilar Report Years Considered
Figure Global Biosimilar Market Size 2014-2025 (Million US$)
Figure Global Biosimilar Sales 2014-2025 (K Units)
Table Global Biosimilar Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Biosimilar Sales by Regions 2014-2019 (K Units)
Table Global Biosimilar Sales Market Share by Regions 2014-2019
Figure Global Biosimilar Sales Market Share by Regions 2014-2019
Figure 2018 Global Biosimilar Sales Market Share by Regions
Table Global Biosimilar Revenue by Regions 2014-2019 (Million US$)
Table Global Biosimilar Revenue Market Share by Regions 2014-2019
Figure Global Biosimilar Revenue Market Share by Regions 2014-2019
Figure 2018 Global Biosimilar Revenue Market Share by Regions
Table Global Biosimilar Sales by Manufacturers (2014-2019) (K Units)
Table Global Biosimilar Sales Share by Manufacturers (2014-2019)
Figure Global Biosimilar Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Biosimilar Revenue by Manufacturers (2014-2019) (Million USD)
Table Biosimilar Revenue Share by Manufacturers (2014-2019)
Figure Biosimilar Value Share by Manufacturers in 2018
Table Key Manufacturers Biosimilar Price (2014-2019) (USD/Unit)
Table Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Biosimilar Product Type
Table Date of International Manufacturers Enter into Biosimilar Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Biosimilar Sales by Product (2014-2019) (K Units)
Table Global Biosimilar Sales Share by Product (2014-2019)
Figure Global Biosimilar Sales Market Share by Product (2014-2019)
Figure Global Biosimilar Sales Market Share by Product in 2018
Table Global Biosimilar Revenue by Product (2014-2019) (Million US$)
Table Global Biosimilar Revenue Share by Product (2014-2019)
Figure Global Biosimilar Revenue Market Share by Product (2014-2019)
Figure Global Biosimilar Revenue Market Share by Product in 2018
Table Biosimilar Price by Product 2014-2019 (USD/Unit)
Table Global Biosimilar Sales by End User (2014-2019) (K Units)
Table Global Biosimilar Sales Share by End User (2014-2019)
Figure Global Sales Biosimilar Market Share by End User (2014-2019)
Figure Global Sales Biosimilar Market Share by End User in 2018
Figure North America Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure North America Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table North America Biosimilar Sales by Countries (2014-2019) (K Units)
Table North America Biosimilar Sales Market Share by Countries (2014-2019)
Figure 2018 North America Biosimilar Sales Market Share by Countries
Table North America Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table North America Biosimilar Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Biosimilar Revenue Market Share by Countries
Figure United States Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure United States Biosimilar Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Canada Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Table North America Biosimilar Sales by Product (2014-2019) (K Units)
Table North America Biosimilar Sales Market Share by Product (2014-2019)
Figure 2018 North America Biosimilar Market Share by Product
Table North America Biosimilar Sales by End User (2014-2019) (K Units)
Table North America Biosimilar Sales Market Share by End User (2014-2019)
Figure 2018 North America Biosimilar Market Share by End User
Figure Europe Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure Europe Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Biosimilar Sales by Countries (2014-2019) (K Units)
Table Europe Biosimilar Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Biosimilar Sales Market Share by Countries
Table Europe Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table Europe Biosimilar Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Biosimilar Revenue Market Share by Countries
Figure Germany Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Germany Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure France Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure France Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure UK Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Italy Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Russia Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Biosimilar Sales by Product (2014-2019) (K Units)
Table Europe Biosimilar Sales Market Share by Product (2014-2019)
Figure 2018 Europe Biosimilar Market Share by Product
Table Europe Biosimilar Sales by End User (2014-2019) (K Units)
Table Europe Biosimilar Sales Market Share by End User (2014-2019)
Figure 2018 Europe Biosimilar Market Share by End User
Figure Asia Pacific Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Biosimilar Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Biosimilar Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biosimilar Sales Market Share by Countries
Table Asia Pacific Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Biosimilar Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biosimilar Revenue Market Share by Countries
Figure China Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure China Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Japan Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Korea Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure India Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure India Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Australia Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Biosimilar Sales by Product (2014-2019) (K Units)
Table Asia Pacific Biosimilar Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Biosimilar Market Share by Product
Table Asia Pacific Biosimilar Sales by End User (2014-2019) (K Units)
Table Asia Pacific Biosimilar Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Biosimilar Market Share by End User
Figure Central & South America Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Biosimilar Sales by Countries (2014-2019) (K Units)
Table Central & South America Biosimilar Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biosimilar Sales Market Share by Countries
Table Central & South America Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Biosimilar Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biosimilar Revenue Market Share by Countries
Figure Brazil Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Biosimilar Sales by Product (2014-2019) (K Units)
Table Central & South America Biosimilar Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Biosimilar Market Share by Product
Table Central & South America Biosimilar Sales by End User (2014-2019) (K Units)
Table Central & South America Biosimilar Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Biosimilar Market Share by End User
Figure Middle East and Africa Biosimilar Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Biosimilar Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Biosimilar Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Biosimilar Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Sales Market Share by Countries
Table Middle East and Africa Biosimilar Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Biosimilar Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Revenue Market Share by Countries
Figure GCC Countries Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Biosimilar Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Biosimilar Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Biosimilar Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Biosimilar Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Market Share by Product
Table Middle East and Africa Biosimilar Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Biosimilar Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Market Share by End User
Table Allergan plc Company Details
Table Allergan plc Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan plc Recent Development
Table BIOCAD Company Details
Table BIOCAD Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BIOCAD Recent Development
Table Biocon Company Details
Table Biocon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocon Recent Development
Table BioXpress Therapeutics Company Details
Table BioXpress Therapeutics Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BioXpress Therapeutics Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Celltrion Company Details
Table Celltrion Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion Recent Development
Table Coherus BioSciences Company Details
Table Coherus BioSciences Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Coherus BioSciences Recent Development
Table Dr. Reddy’s Laboratories Company Details
Table Dr. Reddy’s Laboratories Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dr. Reddy’s Laboratories Recent Development
Table Genor BioPharma Company Details
Table Genor BioPharma Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genor BioPharma Recent Development
Table Intas Pharmaceuticals Limited Company Details
Table Intas Pharmaceuticals Limited Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Intas Pharmaceuticals Limited Recent Development
Table Novartis Company Details
Table Pfizer Company Details
Table Reliance Life Sciences Company Details
Table Global Biosimilar Sales Forecast by Regions 2019-2025 (K Units)
Table Global Biosimilar Sales Market Share Forecast by Regions 2019-2025
Table Global Biosimilar Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Biosimilar Revenue Market Share Forecast by Regions 2019-2025
Table Global Biosimilar Sales Forecast by Product 2019-2025 (K Units)
Table Global Biosimilar Sales Market Share Forecast by Product 2019-2025
Table Global Biosimilar Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Biosimilar Revenue Market Share Forecast by Product 2019-2025
Table Global Biosimilar Sales Forecast by End User 2019-2025 (K Units)
Table Global Biosimilar Sales Market Share Forecast by End User 2019-2025
Figure North America Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Biosimilar Value Chain
Table Biosimilar Customers List
Table Biosimilar Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のバイオシミラーモノクローナル抗体市場：専門的調査 Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are calle…- バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測 Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…
- レミケードバイオシミラーの世界市場：インサイト・予測 Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. The global Remicade Biosimilar market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx…
- 世界のハーセプチンバイオシミラー市場：専門的調査 Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vei…
- 世界のハーセプチンバイオシミラー市場：専門的調査 Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vei…